Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
EMBRACA shows no overall survival benefit with talazoparib
Talazoparib did not confer an overall survival benefit over chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast...
News
Survey: Supportive oncodermatology program improves QOL for cancer patients
A comprehensive supportive program may improve quality of life and reduce treatment interruptions in cancer patients experiencing treatment-...
News
FDA approves ibrutinib-rituximab combo for newly diagnosed CLL, SLL in adults
Ibrutinib (Imbruvica) earns expanded indication for combination with rituximab as frontline treatment for adult CLL and SLL.
News
Doctors push back on treating COVID-19 as HAPE
The pathophysiological mechanism of HAPE is a “fundamentally different phenomenon” than what is seen in COVID-19–related ARDS, experts noted in a...
News
Pepinemab plus avelumab provides disease control in NSCLC
ORLANDO – Treatment with pepinemab/avelumab produced disease control rates of 59% in immunotherapy-resistant patients and 81% in immunotherapy-...
News
Addressing CVD’s role in U.S. maternal mortality: Multispecialty collaboration is needed
“It is vital that mothers who are at increased risk for CVD or have established CVD be referred to a cardiologist for cardiovascular assessment...
News
Update confirms survival benefit with trastuzumab in uterine serous carcinoma
Longer follow-up has revealed improvements in progression-free and overall survival when trastuzumab is added to carboplatin and paclitaxel.
News
Metformin use linked to improved surgery outcomes
“Metformin now joins beta-blockers, statins, and immunonutrition as preoperative agents associated with improved surgical outcomes.”
Article
Managing pediatric heme/onc departments during the pandemic
An international group has devised a plan for preventing the spread of infection, treating COVID-19, and adjusting cancer treatments.
News
Combo elicits responses in advanced cervical cancer
Apatinib plus camrelizumab produced responses regardless of PD-L1 expression.
News
Weight loss intervention fails in endometrial cancer survivors
A weight loss intervention was unsuccessful in obese endometrial cancer survivors.
News
Is protocol-driven COVID-19 respiratory therapy doing more harm than good?
“This is a kind of disease in which you don’t have to follow the protocol – you have to follow the physiology. Unfortunately, many, many doctors...
News
Reports increasingly suggest anosmia/hyposmia can signal early COVID-19 infection
But a WHO expert said the organization needs to look into whether anosmia is an early sign and symptom.